血清环菲林A与急性ST段升高心肌梗塞之间的相关性及其预测值
Yuqi Wang1,2, Long Wang2, Caoyang Fang3
1Graduate School, Bengbu Medical University, Bengbu, Anhui, China.
Frontiers in cardiovascular medicine
|June 11, 2025
概括
在急性ST段升高心肌梗塞 (STEMI) 患者中,血清环菲林A (CyPA) 水平显著更高. 升高的CyPA是一个独立的风险因素,表明其作为STEMI诊断和风险评估的新生物标志物的潜力.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 分子医学是分子医学.
背景情况:
- 急性ST段升高心肌梗塞 (STEMI) 是一种关键的心血管紧急情况,需要及时诊断和治疗.
- 识别新的生物标志物对于改善STEMI患者的治疗结果至关重要.
- 血清环菲林A (CyPA) 已成为心血管疾病发展的潜在因素.
研究的目的:
- 调查血清环菲林A (CyPA) 水平与急性ST段升高心肌梗塞 (STEMI) 之间的关联.
- 评估CyPA作为STEMI风险预测生物标志物的潜力.
- 评估CyPA在急性STEMI患者的诊断和预后价值.
主要方法:
- 一项病例控制研究涉及264名急性STEMI患者和264名健康对照.
- 多变量逻辑回归分析以确定CyPA和STEMI之间的关联.
- 接收器操作特征 (ROC) 曲线分析,重新分类分析,校准曲线和决策曲线分析 (DCA) 以评估预测值.
主要成果:
- 与对照组相比,STEMI患者的血清CyPA水平显著升高 (P < 0.001).
- CyPA被确定为急性STEMI的一个独立风险因素 (OR = 1.15,95% CI: 1.09-1.23).
- 在ROC分析中,CyPA的诊断准确度很高 (AUC=0.994),风险预测模型显著改善 (NRI=0.0682,IDI=0.0438).
结论:
- 血清环菲林A水平与急性STEMI的发生密切相关.
- 作为一种新可靠的生物标志物,CyPA显示出显著的潜力,用于急性STEMI的早期检测和风险分层.
- 需要进一步的研究来阐明CyPA在STEMI病原发生中的确切作用.
更多相关视频
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.2K
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
16.7K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
110
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
110
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
64
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64